Skip to main content

Animations

MJFF Publications

5651 - 5660 of 8404 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • Summary Details
    RESTRICTED
    Title: A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.035
    Best OA location URL:
    Citation Count: 25
  • Summary Details
    RESTRICTED
    Title: Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells
    Journal Name: Frontiers in Immunology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fimmu.2019.00303
    Citation Count: 121
  • Summary Details
    RESTRICTED
    Title: Dual threshold neural closed loop deep brain stimulation in Parkinson disease patients
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.brs.2019.02.020
    Best OA location URL:
    Citation Count: 223
  • Summary Details
    RESTRICTED
    Title: Targeting the Iron-Response Elements of the mRNAs for the Alzheimer’s Amyloid Precursor Protein and Ferritin to Treat Acute Lead and Manganese Neurotoxicity
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms20040994
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Dopamine neuronal protection in the mouse Substantia nigra by GHSR is independent of electric activity
    Journal Name: Molecular Metabolism
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.molmet.2019.02.005
    Citation Count: 11
  • Summary Details
    OPEN
    Title: The role of phosphodiesterase 4 in excessive daytime sleepiness in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.027
    Citation Count: 15
  • Summary Details
    RESTRICTED
    Title: Correction to Conversion of Quinazoline Modulators from Inhibitors to Activators of β-Glucocerebrosidase
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.9b00284
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Network abnormalities among non‐manifesting Parkinson disease related LRRK2 mutation carriers
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/hbm.24543
    Citation Count: 21
  • Summary Details
    OPEN
    Title: SMPD1 mutations, activity, and α‐synuclein accumulation in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27642
    Citation Count: 101
  • Summary Details
    RESTRICTED
    Title: Expert comment to: Novel Xp21.1 deletion associated with unusual features in large McLeod syndrome kindred
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.024
    Best OA location URL:
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.